Genscript Biotech Corp
OTC:GNNSF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genscript Biotech Corp
OTC:GNNSF
|
CN |
|
iQ International AG
F:IQL
|
CH |
|
Office Properties Income Trust
NASDAQ:OPI
|
US |
|
Liberty Latin America Ltd
F:1LL
|
US |
|
I
|
International Seaways Inc
F:IS5
|
US |
|
Watkin Jones PLC
F:0W0
|
UK |
|
Aallon Group Oyj
F:I74
|
FI |
|
I
|
Invictus Energy Ltd
OTC:IVCTF
|
AU |
|
M
|
Mensch und Maschine Software SE
XMUN:MUM
|
DE |
|
J
|
Jet2 PLC
XMUN:DG1
|
UK |
|
Saga Pure ASA
F:SAT
|
NO |
|
Liberty Latin America Ltd
F:1LLC
|
US |
|
G
|
Grupa Azoty SA
SWB:5PL
|
PL |
|
Enovix Corp
F:6Q81
|
US |
|
Y
|
Yubico AB
OTC:YUBCF
|
SE |
|
Office Properties Income Trust
OTC:OPITQ
|
US |
|
M
|
Magnis Energy Technologies Ltd
XMUN:U1P
|
AU |
|
Fuerte Metals Corp
OTC:TALMF
|
CA |
|
Valeo Pharma Inc
F:VP2
|
CA |
|
X
|
XPO Logistics Inc
F:UX2A
|
US |
Wall St Price Targets
GNNSF Price Targets Summary
Genscript Biotech Corp
According to Wall Street analysts, the average 1-year price target for GNNSF is 2.05 USD with a low forecast of 1.62 USD and a high forecast of 3.13 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GNNSF's stock price target?
Price Target
2.05
USD
According to Wall Street analysts, the average 1-year price target for GNNSF is 2.05 USD with a low forecast of 1.62 USD and a high forecast of 3.13 USD.
What is the Revenue forecast for Genscript Biotech Corp?
Projected CAGR
7%
Over the last 12 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 7 years is 7%.
What is the Gross Profit forecast for Genscript Biotech Corp?
Projected CAGR
-2%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 25%. The projected CAGR for the next 3 years is -2%.
What is the Operating Income forecast for Genscript Biotech Corp?
Projected CAGR
-3%
Over the last 12 years, the compound annual growth rate for Operating Income has been 34%. The projected CAGR for the next 7 years is -3%.
